Immunotherapy for Hepatocellular Carcinoma
NCT06241326
·
clinicaltrials.gov ↗
RECRUITING
Status
11000
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Immunotherapy
Interventions
OTHER:
Immunotherapy-based Combination Therapies
Sponsor
The First Affiliated Hospital with Nanjing Medical University